Publications: Dr Marta Buzzetti
Buzzetti M, Gerlinger M
(
2023
)
.
Assessing the toxicity of bispecific antibodies
.
Nature Biomedical Engineering1
-
2
.
Challoner BR, Woolston A, Lau D, Buzzetti M, Fong C, Barber LJ, Anandappa G, Crux R et al.
(
2023
)
.
Genetic and immune landscape evolution in MMR‐deficient colorectal cancer
.
The Journal of Pathology
vol.
262
,
(
2
)
226
-
239
.
Mencel J, Turkes F, Barber L, Challoner B, Buzzetti M, Tran A, Chen H, McCafferty N et al.
(
2023
)
.
P-111 PD1 and LAG3 inhibition as second+ line treatment after EGFR antibody-containing therapy in RAS/BRAF wildtype, MMRp metastatic colorectal cancer
.
Annals of Oncology
vol.
34
,
s53
-
s54
.
Challoner BR, Woolston A, Lau D, Buzzetti M, Barber LJ, Lund T, Sansano HB, von Loga K et al.
(
2022
)
.
Abstract PR012: Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer
.
Cancer Research
.
vol.
82
,
pr012
-
pr012
.